04/11/2024
12:22 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
5:55 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
5:14 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
5:14 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024
5:22 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
7:45 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
6:54 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
03/25/2024
6:28 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
4:27 PM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Fusion Pharmaceuticals Inc. (Subject)
| Form DFAN14A | |
03/19/2024
3:31 PM | AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form F-3ASR | |
03/19/2024
5:02 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
6:12 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2024
6:29 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
5:30 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
5:34 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
9:06 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
9:11 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
6:21 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form CERT | |
03/05/2024
3:40 PM | AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 8-A12B | |
03/04/2024
5:33 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/01/2024
9:39 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2024
5:19 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
8:14 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
8:19 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024
5:08 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
7:32 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/21/2024
7:13 AM | AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/21/2024
5:04 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
8:25 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:51 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/20/2024
6:49 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:12 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:52 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:47 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:27 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2024
9:13 AM | ADC Therapeutics SA (Subject)
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
| Form SC 13G/A | |
02/08/2024
5:40 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2024
9:30 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2024
4:23 PM | AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/19/2024
7:46 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/19/2024
7:31 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
At first glance, this chart looks like nonsense… (Ad) We can isolate the most bullish dates to buy Netflix each and every year…
That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… |
01/10/2024
7:39 PM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/02/2024
9:53 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
7:03 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-T | |
12/27/2023
6:09 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2023
4:25 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/22/2023
5:19 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
9:20 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
4:15 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
4:15 PM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
| Form SC TO-C | |
12/12/2023
5:26 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
10:50 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
10:53 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
5:26 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/24/2023
6:11 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/17/2023
5:36 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023
10:16 AM | AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Cellectis S.A. (Subject)
| Form SC 13D/A | |
11/14/2023
5:39 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:19 AM | AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
SARIN ARADHANA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
9:01 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023
9:05 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023
8:49 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023
8:57 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023
11:24 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023
5:38 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023
6:36 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023
6:36 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2023
9:27 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2023
11:49 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2023
5:55 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/15/2023
10:00 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2023
10:07 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2023
5:59 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/01/2023
9:20 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023
11:23 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023
7:46 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023
5:25 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2023
1:08 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023
12:35 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023
7:30 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2023
4:28 PM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/09/2023
5:38 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2023
5:21 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2023
11:12 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
11:00 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
11:07 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
5:36 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023
5:18 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/25/2023
3:39 PM | AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/22/2023
5:53 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2023
5:43 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Putin and other countries have a plan (Ad) Did you catch that bombshell Tucker Carlson interview with Vladimir Putin?
It’s not about if you like Tucker or think Putin is the devil or whatever.
It's all about the fact that the US dollar might be taking a back seat... and soon.  Click to kickstart your journey to survive in the new economy |
05/09/2023
5:56 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023
5:46 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023
9:25 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023
8:11 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023
6:42 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/27/2023
11:31 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/27/2023
5:44 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2023
11:17 AM | AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
